ADVFN ADVFN

Hot Features

Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Covalon Technologies Ltd (QX)

Covalon Technologies Ltd (QX) (CVALF)

1,5162
-0,0438
(-2,81%)
Fermé 08 Juin 10:00PM

Covalon Technologies Ltd (QX) (CVALF) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
1,5162
( -2,81% )
Prix Achat
1,45
Prix Vente
1,75
Volume échangé
2 900
1,5162 Fourchette du Jour 1,5435
1,1601 Plage de 52 semaines 2,14
Cap du marché
Clôture Veille
1,56
Ouverture
1,533
Dernière Transaction
500
@
1.5162
Dernière heure de transaction
Volume financier
US$ 4 442
VWAP
1,5318
Volume moyen (3 m)
US$ 8 157
Actions en circulation
27 618 077
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
44,15
Bénéfice par action (BPA)
0,05
Chiffre d'affairess (LTM)
32,68M
Bénéfice net (LTM)
1,64M

À propos de Covalon Technologies Ltd (QX)

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company’s platform ... Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company’s platform technologies comprises collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre- and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone. It also offers a medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, perioperative dressings, silicone dressings, vascular access line guards, and wound dressings; and surgical, peri-operative, and infection management products. It sells its products directly and through independent distributors under the ColActive, ColActive PLUS, CovaWound, CovaView, CovaClear IV, IV Clear, SurgiClear, MediClear, and VALGuard brands. The company serves health care providers, such as hospitals, wound care centers, burn centers, extended/alternate care facilities, acute care facilities, home health care agencies, and physicians’ offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Site Web
Siège social
Mississauga, Canada
Fondé
-
Covalon Technologies Ltd (QX) est coté dans le secteur Healthcare de la OTC Markets avec le ticker CVALF. Le dernier cours de clôture d'Covalon Technologies (QX) était de US$1,56. Au cours de la dernière année, les actions de Covalon Technologies (QX) ont été négociées dans une fourchette de prix de US$ 1,1601 à US$ 2,14.

Covalon Technologies (QX) compte actuellement 27 618 077 actions en circulation. La capitalisation boursière d'Covalon Technologies (QX) est de US$41,87 million. Covalon Technologies (QX) a un ratio cours/bénéfice (ratio PE) de 44.15.

CVALF Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.0778-4.880803011291.5941.611.45112191.55688409CS
40.12629.079136690651.391.631.3773961.5054999CS
120.196214.86363636361.321.631.21170691.39677432CS
260.12619.071289835261.39011.631.160193021.33786523CS
52-0.197295-11.51418591831.7134952.141.160197661.49744925CS
1560.02621.758389261741.493.080.7285123181.93872731CS
2600.192714.55987910841.32353.080.7285103641.9168625CS

CVALF - Frequently Asked Questions (FAQ)

What is the current Covalon Technologies Ltd (QX) share price?
The current share price of Covalon Technologies Ltd (QX) is US$ 1,5162
How many Covalon Technologies Ltd (QX) shares are in issue?
Covalon Technologies Ltd (QX) has 27 618 077 shares in issue
What is the market cap of Covalon Technologies Ltd (QX)?
The market capitalisation of Covalon Technologies Ltd (QX) is USD 41,87M
What is the 1 year trading range for Covalon Technologies Ltd (QX) share price?
Covalon Technologies Ltd (QX) has traded in the range of US$ 1,1601 to US$ 2,14 during the past year
What is the PE ratio of Covalon Technologies Ltd (QX)?
The price to earnings ratio of Covalon Technologies Ltd (QX) is 44,15
What is the cash to sales ratio of Covalon Technologies Ltd (QX)?
The cash to sales ratio of Covalon Technologies Ltd (QX) is 1,86
What is the registered address of Covalon Technologies Ltd (QX)?
The registered address for Covalon Technologies Ltd (QX) is 1660 Tech Avenue, Mississauga, Ontario, L4W 5S7
What is the Covalon Technologies Ltd (QX) website address?
The website address for Covalon Technologies Ltd (QX) is covalon.com
Which industry sector does Covalon Technologies Ltd (QX) operate in?
Covalon Technologies Ltd (QX) operates in the Biotechnology & Life Sciences sector

CVALF Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock